Q1 2025 Holdings
Filed 2025-05-15 | 13 holdings | $169.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kestra Med Technologies Ltd.(KMTS) | Common Stock | G52441105 | $44.8M | 1,795,893 | 26.4% |
| Bicara Therapeutics Inc.(BCAX) | Common Stock | 055477103 | $28.7M | 2,204,650 | 17.0% |
| Beta Bionics Inc.(BBNX) | Common Stock | 08659B102 | $24.3M | 1,988,287 | 14.4% |
| Nuvation Bio(NUVB) | Common Stock Class A | 67080N101 | $23.0M | 13,072,340 | 13.6% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $19.3M | 1,975,203 | 11.4% |
| Upstream Bio Inc.(UPB) | Common Stock | 91678A107 | $12.5M | 2,036,293 | 7.4% |
| Lexeo Therapeutics(LXEO) | Common Stock | 52886X107 | $4.1M | 1,184,636 | 2.4% |
| Alumis Inc.(ALMS) | Common Stock | 022307102 | $4.0M | 653,223 | 2.4% |
| Ikena Oncology | Common Stock | 45175G108 | $2.9M | 2,249,123 | 1.7% |
| enGene Holdings Inc.(ENGN) | Common Stock | 29286M105 | $2.4M | 526,357 | 1.4% |
| Immunic Inc.(IMUX) | Common Stock | 4525EP101 | $1.9M | 1,788,160 | 1.2% |
| Sana Biotechnology, Inc.(SANA) | Common Stock | 799566104 | $1.4M | 843,750 | 0.8% |
| enGene Holdings Inc.(ENGNW) | Warrant | 29286M113 | $192.9K | 321,502 | 0.1% |